Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804

Turnaround Potential

In 6 Starfolio Baskets

Download real time

1340.40 4.70 (0.35%)

New 52W High in past week

961.3K

NSE+BSE Volume

NSE 09 Apr, 2026 3:31 PM (IST)

-

Beta 1Year

Very Low volatility

Positive Trial

Aurobindo Pharma unit reports positive Phase 3 results for BP11, a drug for repeated skin allergies See details

Aurobindo Pharma RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Aurobindo Pharma technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis